IGF1 and neoplasm: Although many pro-tumorigenic effects of IGF axis activation are mediated via IGF-1Rs expressed by target epithelial, mesenchymal, and endothelial cells, it is increasingly recognized that IGFs also influence anti-tumor immunity.